메뉴 건너뛰기




Volumn 50, Issue 11, 2009, Pages 1090-1094

Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore

Author keywords

17q gain; 1p deletion; Fluorescence in situ hybridisation; Genetic markers; MYCN amplification; Neuroblastoma

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER TISSUE; CELL DIFFERENTIATION; CHILD; CHILDHOOD CANCER; CHROMOSOME 17Q; CHROMOSOME 1P; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; INTERMETHOD COMPARISON; MALE; MARKER GENE; MITOSIS; MYCN GENE; NEUROBLASTOMA; NEWBORN; PRESCHOOL CHILD; PRIMARY TUMOR; TUMOR GENE; WORLD HEALTH ORGANIZATION;

EID: 76649104317     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (9)

References (29)
  • 1
    • 0021226066 scopus 로고
    • Histopathologic prognostic factors in neuroblastic tumours: Definition of subtypes of gaglioneuroblastoma and an age-linked classification of neuroblastomas
    • Shimada H, Chatten J, Newton WA Jr, et al. Histopathologic prognostic factors in neuroblastic tumours: definition of subtypes of gaglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984; 73:405-16.
    • (1984) J Natl Cancer Inst , vol.73 , pp. 405-416
    • Shimada, H.1    Chatten, J.2    Newton Jr, W.A.3
  • 2
    • 0033565765 scopus 로고    scopus 로고
    • The International Neuroblastoma Pathology Classification (the Shimada system)
    • Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999; 86:364-72.
    • (1999) Cancer , vol.86 , pp. 364-372
    • Shimada, H.1    Ambros, I.M.2    Dehner, L.P.3
  • 3
    • 12744262848 scopus 로고    scopus 로고
    • The biologic basis for neuroblastoma heterogeneity and risk stratification
    • Maris JM. The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr 2005; 17:7-13.
    • (2005) Curr Opin Pediatr , vol.17 , pp. 7-13
    • Maris, J.M.1
  • 4
    • 0035889955 scopus 로고    scopus 로고
    • Histology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumours: A report from the Children's Cancer Group
    • Goto S, Umehara S, Gerbing RB, et al. Histology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumours: a report from the Children's Cancer Group. Cancer 2001; 92:2699-708.
    • (2001) Cancer , vol.92 , pp. 2699-2708
    • Goto, S.1    Umehara, S.2    Gerbing, R.B.3
  • 5
    • 0033600283 scopus 로고    scopus 로고
    • Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma
    • Bown N, Cotterill S, Lastowska M, et al. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 1999; 340:1954-61.
    • (1999) N Engl J Med , vol.340 , pp. 1954-1961
    • Bown, N.1    Cotterill, S.2    Lastowska, M.3
  • 6
    • 0029121989 scopus 로고
    • Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis
    • Shimada H, Stram DO, Chatten J, et al. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 1995; 87:1470-6.
    • (1995) J Natl Cancer Inst , vol.87 , pp. 1470-1476
    • Shimada, H.1    Stram, D.O.2    Chatten, J.3
  • 7
    • 33845939529 scopus 로고    scopus 로고
    • Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma
    • Altungoz O, Aygun N, Tumer S, et al. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma. Cancer Genet Cytogenet 2007; 172:113-9.
    • (2007) Cancer Genet Cytogenet , vol.172 , pp. 113-119
    • Altungoz, O.1    Aygun, N.2    Tumer, S.3
  • 8
    • 0001083469 scopus 로고    scopus 로고
    • Neuroblastic tumors of adrenal gland and sympathetic nervous system
    • Kleihues P, Cavenee WK, eds, 2nd ed. Lyon: IARC Press
    • Schwab M, Shimada H, Joshi V, Brodeur GM. Neuroblastic tumors of adrenal gland and sympathetic nervous system. In: Kleihues P, Cavenee WK, eds. Pathology and Genetics of Tumours of the Nervous System. 2nd ed. Lyon: IARC Press, 2000: 153-61.
    • (2000) Pathology and Genetics of Tumours of the Nervous System , pp. 153-161
    • Schwab, M.1    Shimada, H.2    Joshi, V.3    Brodeur, G.M.4
  • 9
    • 0003484109 scopus 로고    scopus 로고
    • Brodeur GM, Sawada T, Tsuchida Y, et al, eds, 1st ed. Amsterdam: Elsevier Science BV
    • Brodeur GM, Sawada T, Tsuchida Y, et al, eds. Neuroblastoma. 1st ed. Amsterdam: Elsevier Science BV, 2000.
    • (2000) Neuroblastoma
  • 10
    • 0037601662 scopus 로고    scopus 로고
    • Quality assessment of genetic markers used for therapy stratification
    • Ambros IM, Benard J, Boavida M, et al. Quality assessment of genetic markers used for therapy stratification. J Clin Oncol 2003; 21:2077-84.
    • (2003) J Clin Oncol , vol.21 , pp. 2077-2084
    • Ambros, I.M.1    Benard, J.2    Boavida, M.3
  • 11
    • 0034061843 scopus 로고    scopus 로고
    • Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study
    • Schmidt ML, Lukens JN, Seeger RC, et al. Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. J Clin Oncol 2000; 18:1260-8.
    • (2000) J Clin Oncol , vol.18 , pp. 1260-1268
    • Schmidt, M.L.1    Lukens, J.N.2    Seeger, R.C.3
  • 12
    • 33750325100 scopus 로고    scopus 로고
    • Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study
    • Moreau LA, McGrady P, London WB, et al. Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study. Clin Cancer Res 2006; 12:5693-7.
    • (2006) Clin Cancer Res , vol.12 , pp. 5693-5697
    • Moreau, L.A.1    McGrady, P.2    London, W.B.3
  • 13
    • 0034928910 scopus 로고    scopus 로고
    • Genetic heterogeneity and clonal evolution in neuroblastoma
    • Mora J, Cheung NK, Gerald WL. Genetic heterogeneity and clonal evolution in neuroblastoma. Br J Cancer 2001; 85:182-9.
    • (2001) Br J Cancer , vol.85 , pp. 182-189
    • Mora, J.1    Cheung, N.K.2    Gerald, W.L.3
  • 14
    • 0035677931 scopus 로고    scopus 로고
    • Neuroblastoma tumour genetics: Clinical and biological aspects
    • Bown N. Neuroblastoma tumour genetics: clinical and biological aspects. J Clin Pathol 2001; 54:897-910.
    • (2001) J Clin Pathol , vol.54 , pp. 897-910
    • Bown, N.1
  • 15
    • 0028944776 scopus 로고
    • Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma
    • Caron H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol 1995; 24:215-21.
    • (1995) Med Pediatr Oncol , vol.24 , pp. 215-221
    • Caron, H.1
  • 16
    • 0031409099 scopus 로고    scopus 로고
    • Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. UK Children's Cancer Study Group and the UK Cancer Cytogenetics Group
    • Lastowska M, Cotterill S, Pearson AD, et al. Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. UK Children's Cancer Study Group and the UK Cancer Cytogenetics Group. Eur J Cancer 1997; 33:1627-33.
    • (1997) Eur J Cancer , vol.33 , pp. 1627-1633
    • Lastowska, M.1    Cotterill, S.2    Pearson, A.D.3
  • 17
    • 0033732678 scopus 로고    scopus 로고
    • Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status
    • Cunsolo CL, Bicocchi MP, Petti AR, Tonini GP. Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status. Br J Cancer 2000; 83:1295-300.
    • (2000) Br J Cancer , vol.83 , pp. 1295-1300
    • Cunsolo, C.L.1    Bicocchi, M.P.2    Petti, A.R.3    Tonini, G.P.4
  • 18
    • 13344275864 scopus 로고    scopus 로고
    • Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma
    • Caron H, van Sluis P, de Kraker J, et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 1996; 334:225-30.
    • (1996) N Engl J Med , vol.334 , pp. 225-230
    • Caron, H.1    van Sluis, P.2    de Kraker, J.3
  • 19
    • 0034015079 scopus 로고    scopus 로고
    • Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: A Children's Cancer Group Study
    • Maris JM, Weiss MJ, Guo C, et al. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group Study. J Clin Oncol 2000; 18:1888-99.
    • (2000) J Clin Oncol , vol.18 , pp. 1888-1899
    • Maris, J.M.1    Weiss, M.J.2    Guo, C.3
  • 20
    • 0036115740 scopus 로고    scopus 로고
    • Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations
    • Splitz R, Hero B, Westermann F, et al. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Genes Chromosomes Cancer 2002; 34:299-305.
    • (2002) Genes Chromosomes Cancer , vol.34 , pp. 299-305
    • Splitz, R.1    Hero, B.2    Westermann, F.3
  • 21
    • 28144453057 scopus 로고    scopus 로고
    • Chromosome 1p and 11q deletions and outcome in neuroblastoma
    • Attiyeh EF, London WB, Mosse YP, et al. Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 2005; 353:2243-53.
    • (2005) N Engl J Med , vol.353 , pp. 2243-2253
    • Attiyeh, E.F.1    London, W.B.2    Mosse, Y.P.3
  • 23
    • 0034598797 scopus 로고    scopus 로고
    • High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
    • Islam A, Kageyama H, Takada N, et al. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 2000; 19:617-23.
    • (2000) Oncogene , vol.19 , pp. 617-623
    • Islam, A.1    Kageyama, H.2    Takada, N.3
  • 24
    • 85047695614 scopus 로고    scopus 로고
    • Godfried MB, Veenstra M, v Sluis P, et al. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene 2002; 21:2097-101.
    • Godfried MB, Veenstra M, v Sluis P, et al. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene 2002; 21:2097-101.
  • 25
    • 38749131235 scopus 로고    scopus 로고
    • Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomics
    • Vandesompele J, Michels E, De Preter K, et al. Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomics. Int J Cancer 2008; 122:1177-82.
    • (2008) Int J Cancer , vol.122 , pp. 1177-1182
    • Vandesompele, J.1    Michels, E.2    De Preter, K.3
  • 26
    • 0037446975 scopus 로고    scopus 로고
    • PPM1D is a potential target for 17q gain in neuroblastoma
    • Saito-Ohara F, Imoto I, Inoue J, et al. PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res 2003; 63:1876-83.
    • (2003) Cancer Res , vol.63 , pp. 1876-1883
    • Saito-Ohara, F.1    Imoto, I.2    Inoue, J.3
  • 27
    • 0036752748 scopus 로고    scopus 로고
    • Interphase fluorescence in situ hybridization detection of chromosome 17 and 17q region gains in neuroblastoma: Are they secondary events?
    • Trakhtenbrot L, Cohen N, Betts DR, et al. Interphase fluorescence in situ hybridization detection of chromosome 17 and 17q region gains in neuroblastoma: are they secondary events? Cancer Genet Cytogenet 2002; 137:95-101.
    • (2002) Cancer Genet Cytogenet , vol.137 , pp. 95-101
    • Trakhtenbrot, L.1    Cohen, N.2    Betts, D.R.3
  • 28
    • 10944248244 scopus 로고    scopus 로고
    • New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status
    • Simon T, Spitz R, Faldum A, Hero B, Berthold F. New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status. J Pediatr Hematol Oncol 2004; 26:791-6.
    • (2004) J Pediatr Hematol Oncol , vol.26 , pp. 791-796
    • Simon, T.1    Spitz, R.2    Faldum, A.3    Hero, B.4    Berthold, F.5
  • 29
    • 3543023204 scopus 로고    scopus 로고
    • Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
    • Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30:e57
    • (2002) Nucleic Acids Res , vol.30
    • Schouten, J.P.1    McElgunn, C.J.2    Waaijer, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.